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STUDY PROTOCOL
Linking Infectious and Narcology 
Care (LINC) in Russia: design, intervention 
and implementation protocol
Natalia Gnatienko1, Steve C. Han2, Evgeny Krupitsky3,4, Elena Blokhina3, Carly Bridden1, Christine E. Chaisson5, 
Debbie M. Cheng6, Alexander Y. Walley2, Anita Raj7 and Jeffrey H. Samet2,8*
Abstract 
Background: Russia and Eastern Europe have one of the fastest growing HIV epidemics in the world. While coun-
tries in this region have implemented HIV testing within addiction treatment systems, linkage to HIV care from these 
settings is not yet standard practice. The Linking Infectious and Narcology Care (LINC) intervention utilized peer-led 
strengths-based case management to motivate HIV-infected patients in addiction treatment to obtain HIV care. This 
paper describes the protocol of a randomized controlled trial evaluating the effectiveness of the LINC intervention in 
St. Petersburg, Russia.
Methods/design: Participants (n = 349) were recruited from the inpatient wards at the City Addiction Hospital in St. 
Petersburg, Russia. After completing a baseline assessment, participants were randomly assigned to receive either the 
LINC intervention or standard of care. Participants returned for research assessments 6 and 12 months post-baseline. 
Primary outcomes were assessed via chart review at HIV treatment locations.
Discussion: LINC holds the potential to offer an effective approach to coordinating HIV care for people who inject 
drugs in Russia. The LINC intervention utilizes existing systems of care in Russia, minimizing adoption of substantial 
infrastructure for implementation.
Trial Registration NCT01612455
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Background
The HIV epidemic in Russia and Eastern Europe is one 
of the most rapidly expanding HIV epidemics in the 
world, with transmission risk primarily from injection 
drug use [1–7]. The total number of people living with 
HIV in Russia is estimated at 850,000–1,300,000 [8]. 
The strategy to seek, test, treat and retain (STTR) is a 
useful paradigm to facilitate progress along the HIV 
cascade from identification (i.e., HIV testing) to treat-
ment and viral suppression [9, 10]. Russia and other 
countries in the region were early adopters of routine 
HIV testing within the established addiction treatment 
systems (e.g., narcology hospitals as referred to in Rus-
sia), but have failed to effectively link HIV-infected 
patients to HIV care [3, 4, 11]. This represents a missed 
opportunity. It is estimated that 80 % of those infected 
with HIV in Russia are people who inject drugs (PWID) 
and up to 33  % of Russian PWID receiving narcology 
treatment are HIV-infected [6, 12]. Yet, PWID account 
for only 20–30  % of patients receiving antiretroviral 
therapy (ART) [6, 13]. As was the case in the United 
States in the 1990s, delayed or non-receipt of HIV 
medical care, particularly among PWID, is common in 
Russia, even though many are aware of their diagnosis 
[9, 11, 14–17]. Recently, the Russian AIDS treatment 
system began using case managers (CMs) to help retain 
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patients in HIV care [18]. Unfortunately, these efforts 
have not been focused on care initiation, nor are they 
being operationalized in narcology treatment settings. 
In addition, existing CMs do not address the unique 
challenges faced by Russian PWID that impact their 
retention in HIV care, such as stigma and the compet-
ing priorities for those with addiction [19–21]. Helping 
PWID face the challenges of stigma and their addiction 
is vital given the difficulty of initiating and retaining 
PWID in HIV care [17].
To address this recognized gap in HIV care in Russia, 
as well as elsewhere in the world, we sought to test an 
integrated behavioral and structural intervention (i.e., 
an intervention addressing behavioral risks and struc-
turally linking substance abuse treatment and HIV care) 
to improve the treat and retain dimensions of the STTR 
paradigm. This intervention, Linking Infectious and 
Narcology Care (LINC), involved peer-led strengths-
based case management to support and motivate HIV-
infected PWID in a narcology hospital in St. Petersburg, 
Russia to link with HIV medical care, thus facilitating 
coordinated care between the narcology and HIV medi-
cal systems [22]. Here we describe study design, inter-
vention and control procedures, and implementation of 
the protocol.
Study methods/design
We conducted a randomized controlled trial to assess 
the effectiveness of the LINC intervention among HIV-
infected Russian PWID compared to standard of care 
treatment in Russia on the following outcomes: (1) ini-
tiation of HIV care (i.e., 1 or more visit to HIV medical 
care) within 6 months of enrollment; (2) retention in HIV 
care (i.e., 1 or more visit to HIV medical care in two con-
secutive 6  month periods) within 12  months of enroll-
ment; (3) appropriate HIV care (i.e., prescribed ART if 
CD4 cell count was <350 or having a second CD4 count 
if CD4  >  350) within 12  months of enrollment; and (4) 
improved HIV health outcomes (i.e., CD4 cell count) 
12 months after enrollment.
Study setting
Participants were recruited from inpatient wards at the 
City Addiction Hospital in St. Petersburg, Russia from 
July 2012 through May 2014. The St. Petersburg City 
Addiction Hospital is a government-funded 500-bed 
hospital, providing free addiction care to residents of 
the city of St. Petersburg, who are registered as having 
a substance use disorder (drug or alcohol). The hospital 
provides detoxification, early stabilization, including the 
treatment of co-morbid psychiatric and somatic disor-
ders, and inpatient rehabilitation. Typical length of stay 
for hospitalized patients is one to 3 weeks.
Participants and recruitment
The study enrolled 349 participants who met the fol-
lowing inclusion criteria: (1) age 18–70  years; (2) HIV-
infected; (3) hospitalized at the narcology hospital; (4) 
history of injection drug use; (5) agree to CD4 cell count 
testing; (6) have two contacts to assist with follow-up; (7) 
live within 100 km of St. Petersburg; (8) have a telephone; 
(9) willing to receive HIV care at Botkin Infectious Dis-
ease Hospital. The following served as exclusion criteria 
for study enrollment: (1) currently on ART; (2) not fluent 
in Russian; (3) cognitive impairment precluding informed 
consent.
All HIV-infected patients admitted to the intensive care 
and detoxification/rehabilitation departments of the City 
Addiction Hospital were eligible for screening. At the 
City Addiction Hospital, information about a patient’s 
HIV status is routinely collected in the admission depart-
ment and noted on the front page of the patient’s medi-
cal chart. Three times a week, a nurse identified medical 
charts of HIV-infected patients who had not been pre-
viously screened. Patients were screened 1–5  days after 
admission to the narcology hospital and after treatment 
for most severe initial withdrawal symptoms. Screening 
was conducted by Research Assessors (RAs) who were 
City Addiction Hospital physicians with narcology sub-
specialty training (i.e., narcologists). They had access to 
medical charts and were trained on the research proto-
col by the Russian and US study investigators (EB, CC). 
Narcologists who were not involved with the patient’s 
medical care approached the patient to assess study eli-
gibility. The RA initiated pre-screening procedures of 
potentially appropriate patients by reviewing the medical 
chart to assess exclusion criteria (e.g., significant cogni-
tive impairment, currently on ART).
Once a patient was identified as being HIV-infected 
based on chart review, but not having evident signifi-
cant cognitive impairment, not on ART, and not previ-
ously approached about the LINC study, the RA met with 
the patient in a private location (e.g., hospital room or 
exam room) to briefly describe the study and conduct the 
screening to confirm the presence of inclusion criteria 
and absence of exclusion criteria. The RA offered eligible 
participants enrollment into the study and as appropri-
ate, administered and documented the informed consent. 
Out of 382 participants, whose charts were reviewed as 
part of the pre-screening process, 370 (96.9 %) were eligi-
ble and agreed to be screened. Out of those, 359 (97.0 %) 
met eligibility criteria to participate in the study. The 
main reason for ineligibility was having taken ART in the 
past 30  days (Table  1). Out of those who were eligible, 
349 (97.2 %) were enrolled and randomized (Fig. 1).
After enrollment into the study, the RAs asked par-
ticipants if they were newly diagnosed with HIV and if 
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so, whether or not they had received post-test coun-
seling. The RA administered HIV post-test counseling to 
any newly diagnosed patients who had not yet received 
it. Over the course of the study, six patients were newly 
diagnosed and received post-test counseling from the 
study RA. The post-test counseling typically lasted 
10  min and was conducted according to the guidelines 
of the Russian Ministry of Health, which were consistent 
with the US Centers for Disease Control and Prevention 
(CDC) recommendations. Following post-test coun-
seling, if indicated, the RA collected locator information 
for the participant and alternate contacts. The RA then 
administered the baseline assessment and randomized 
the participant into the intervention or control group. 
The RA accompanied the participant to the laboratory for 
CD4 testing and provided the participant with a resource 
card containing harm reduction information and contact 
information for the local HIV clinic (Fig. 2).
Randomization
Randomization was stratified on two factors: (1) whether 
an outpatient appointment with an infectious disease 
physician occurred in the 12 months prior to enrollment, 
and (2) whether the participant reported ever having 
been hospitalized for his or her HIV infection. Stratified 
randomization was used in order to ensure balance with 
respect to these potential confounding factors. Blocked 
randomization using random block sizes was used within 
each stratum. A computer-generated randomization 
table was created allowing randomization to occur via a 
custom web-application. Due to the nature of the inter-
vention, participants and case managers could not be 
blinded to group assignment. However, the study was 
designed to minimize measurement bias by having the 
baseline assessment administered prior to randomization 
and by concealing randomization assignment from the 
follow-up assessors.
Intervention
The LINC intervention was a behavioral and structural 
intervention designed to support and motivate HIV-
infected PWID to engage in (i.e., initiate and retain) HIV 
medical care and ultimately improve their HIV outcomes. 
This intervention involved coordination between the nar-
cology and HIV systems of care, utilizing HIV strengths-
based case management delivered via five one-on-one 
sessions by a peer case manager (i.e., HIV-infected men 
and women in recovery from addiction) to help motivate 
and reduce barriers to HIV care. The initial session was 
designed to be delivered in the narcology hospital and 
included provision of CD4 test results by the case man-
ager (CM) in a timely fashion, to increase engagement 
in HIV medical care. If the participant departed the City 
Addiction Hospital prior to having their initial interven-
tion session, then this encounter was pursued outside of 
the hospital. Subsequent sessions were conducted upon 
discharge from the narcology hospital over a 6-month 
period in community (e.g., parks, coffee shops) or 
clinic locations, agreed upon by the case manager and 
participant.
The LINC intervention was developed via adaptation 
of the Antiretroviral Treatment Access Study (ARTAS) 
intervention for use in the Russian setting and specifi-
cally with PWID [22]. The ARTAS model was developed 
in the United States for a spectrum of HIV-infected per-
sons and not specifically for PWID. Consistent with the 
ARTAS model, the LINC intervention used a strengths-
based case management approach in which a trained CM 
met individually with clients to motivate them to engage 
in HIV medical care by supporting the recognition of 
their own strengths to make positive changes in their 
lives. This approach was grounded in a Social Cognitive 
Theory (SCT) and Psychological Empowerment Theory 
(PET) framework [23, 24].
SCT posits that behavioral goals (e.g., HIV care ini-
tiation and maintenance) are achieved when individu-
als (1) perceive their capacity to engage in the behavior 
(self-efficacy), (2) have the skills to manage “triggers,” 
such as substance use that can impede the behavior 
(self-management) and (3) believe the behavior will 
be both beneficial and socially supported (outcome 
expectancies) [23]. Additionally, SCT recognizes that 
such factors can only impact behavior, such as engage-
ment in HIV care, in an environment where access to 
services exists [25]. Hence, the LINC intervention 
offered strengths-based case management in the addic-
tion treatment setting and in transition to the HIV care 
setting in order to (1) build self-efficacy, (2) enable 
self-management, and (3) increase outcome expectan-
cies regarding engaging in HIV care via education and 
social support.
Table 1 Reasons for ineligibility for study participation
n
Total ineligible during pre-screening
 HIV diagnosis not confirmed 4
 Significant cognitive impairment 1
Total ineligible on screener
 Taken ART in past 30 days 4
 Not enrolled due to RA discretion 3
 Never injected drugs 1
 Not available for CD4 testing 1
 Not willing to receive care at Botkin 1
 Does not have two contacts to assist with follow-up 1
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Use of SCT is predicated on individuals having some 
degree of personal empowerment to create change 
in their own lives. Given the marginalization of HIV-
infected PWID in Russia, this approach benefits from use 
of PET to bolster the effectiveness of the SCT-derived 
intervention [24]. According to PET, empowerment, 
the process by which individuals gain power over their 
own lives, occurs with opportunities to (1) influence the 
system (e.g., HIV clinical care) affecting them (intrap-
ersonal), (2) have control over their role in transactions 
(interactional), and (3) contribute to changing the system 
and its interactions with them to better meet their health 
needs respectfully (behavioral). The LINC strengths-
based HIV case management was designed to promote 
patient empowerment by providing education on how to 
control the HIV and addiction care they receive (intrap-
ersonal), their right to receive and how to advocate for 
quality HIV and addiction care (interactional), and peer 
HIV case management by HIV-infected PWID in recov-
ery to model for patients how to pursue healthy and pro-
ductive lives (behavioral).
Six peer case managers (CMs), who were HIV-infected 
and in recovery (i.e., history of substance use disorder), 
were hired and trained to conduct the LINC intervention. 
All CMs had experience providing case management to 
substance using and/or HIV-infected adults in St. Peters-
burg. The LINC intervention was developed, and train-
ing was organized and led by the team of US and Russian 
investigators. Researchers (AR, JS, EB) were trained by 
Richard Rapp, MSW in a two-day training in Boston, 
Assessed for eligibility (n=382)
Excluded (n= 12)
-Not meeting inclusion criteria (n=5)
-Declined to participate (n=7) 
6-month follow-up assessment
Allocated to intervention group (n=174) Allocated to control group (n=175)
Randomized (n= 349)
Completed Baseline Interview (n= 349)
12-month follow-up assessment
Completed Screener (n=370)
Excluded (n= 21)
-Not meeting inclusion criteria (n=11)
-Declined to participate (n=10) 
Fig. 1 CONSORT diagram
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which focused on the Antiretroviral Treatment Access 
Study (ARTAS) Linkage Case Management (ALCM) 
method [22]. Over the course of 3 days, researchers (AR, 
JS, EB) trained the CMs in St. Petersburg, providing them 
with an overview of the theoretical framework, assess-
ment techniques and the LINC intervention. Researchers 
modeled and role-played the intervention delivery for the 
CMs to assure the use of a strengths-based approach. A 
simultaneous interpreter was used to allow the role-play-
ing sessions to be critiqued. The team covered a number 
of topics with the CMs: HIV in PWID populations, addic-
tion treatment options, HIV care, and antiretroviral ther-
apy adherence. Booster trainings were conducted annually 
and as necessary, based on findings from quality assurance 
efforts. These intensive trainings, as well as the monitor-
ing and observation for quality assurance were designed to 
limit potential variability due to individual CMs.
Each participant randomized to the intervention was 
assigned a specific CM, to ensure that the participants 
would be distributed evenly among the CMs. Upon 
randomization to the intervention, the RA notified the 
assigned CM via text message or phone call to meet with 
the participant at the City Addiction Hospital within 
3 days. Reassignment to an alternate CM did occasionally 
occur due to CM illness, but efforts were made to main-
tain the same CM for each participant for the duration of 
the intervention.
The first case management session was held at the 
City Addiction Hospital with sessions 2–5 occurring 
anywhere in the community, or via phone if necessary. 
A session could also occur in the HIV clinic, to facili-
tate HIV care acquisition. The first session consisted of 
ascertaining the client’s strengths and developing goals 
related to obtaining HIV care, as well as discussing with 
the client their most recent CD4 cell count and benefits 
of HIV care (see Table 2 for a complete list of first session 
components). Follow-up sessions were based on a simi-
lar curriculum to the first session, but were intended to 
be shorter and more focused on meeting previously set 
goals and creating new goals based on the client’s previ-
ously self-identified strengths. Emphasis was placed on 
CMs guiding the client towards receiving HIV care with-
out coercion, and supporting the client’s strengths and 
capacities to achieve his/her goals.
LINC Resource Card
HIV Care
If you would like to see a doctor for your HIV infection, please make an appointment at 
the Botkin Infectious Disease Center by calling XXX-XXX-XXXX or going to 
Mirgorodskaya street, 3.
If you start using drugs
Important steps to stay safe include:
• Use less than you did before you got clean.  Your body will be more sensitive 
than usual to the effects of the drug (your tolerance is likely to be lower).
• Let someone else know that you are using, so he or she can help you if you 
overdose.
• Avoid mixing multiple drugs. This increases your risk of overdose.
• From the pharmacy or the risk reduction agency, access clean needles and 
bleach kits in order reduce the risk of transmitting HIV to someone else or skin 
infections.
Safer Sex
Important steps for safer sex include:
• Kissing, lying close to each other, caressing and massaging each other are all 
safer sex. The safest sex is no sex.
• If you have penetrative sex, always use condoms.
Fig. 2 LINC resource card containing harm reduction information and contact information for the local HIV clinic
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The CM contacted participants between case manage-
ment sessions by phone, text message, and/or email to 
remind them of upcoming appointments and to check-
in. CMs used their clinical judgment to determine how 
frequently to provide check-in calls. At a minimum, a 
reminder text message and/or email using a standard 
script was sent to participants within a week prior to 
their next case management session. CMs maintained 
detailed clinical notes and contact logs, as well as brief 
tracking forms to record the location and duration of ses-
sions and check-ins.
Control condition
Participants randomized to the control condition 
received the narcology hospital’s standard of care. With 
regard to linkage to HIV medical care, RAs provided all 
participants with a resource card containing harm reduc-
tion information and contact information for the local 
HIV clinic (Fig. 2).
Implementation assessments
Several implementation assessments were utilized to 
determine the adherence to and the fidelity of the LINC 
intervention.
Case Manager Checklists were completed by the CMs 
during all case management sessions. These checklists 
served to identify the content for the intervention, pro-
viding an outline of the CM activities and discussion 
points.
Case Manager Observations were conducted by the 
Russian project manager via audiotaped recordings of 
the first three sessions for each CM and 10 % of all subse-
quent sessions. A checklist was completed by the Russian 
project manager to document the level of CM adherence 
to the content and participant engagement.
Clinical Supervision and Feedback was an integral 
component of the process evaluation strategy. The Rus-
sian project manager, a trained physician narcologist, 
reviewed CM clinical notes, contact logs, CM checklists 
and observation forms, and met with CMs monthly to 
provide feedback and conduct any additional training as 
needed. Feedback was provided using a strengths-based 
supervision approach. The Russian project manager met 
regularly with the research team’s behavioral psycholo-
gist (AR) and the US project manager to discuss any chal-
lenges that were raised during the clinical supervision 
meetings with CMs and throughout the course of the 
intervention.
Case Manager Evaluation Forms assessed CM satisfac-
tion with the LINC intervention. Every 3  months after 
the start of the LINC intervention, the CMs provided 
their opinions on the effectiveness of the intervention 
and whether or not it helped participants link to HIV 
care. The evaluation also asked CMs about any difficul-
ties they encountered during the intervention.
Participant Satisfaction Survey was a self-administered 
survey completed by study participants at the time of 
their 6-month study research assessment. It assessed par-
ticipant satisfaction with case management sessions and 
whether CMs helped participants with any health issues 
related to HIV infection or addiction.
Research assessments
Study interviews were conducted face-to-face by trained 
research staff at baseline (pre-randomization) at the nar-
cology hospital, and at 6 and 12-months post-enrollment 
at First St. Petersburg Pavlov State Medical University. In 
the event of readmission, follow-up research interviews 
were occasionally conducted at the City Addiction Hos-
pital. Participants were compensated for completion of 
each study visit (Table 3).
The components of the baseline and follow-up assess-
ments and study activities are shown in Tables 3, 4 and 
5. Assessment components were selected to maximize 
harmonization efforts with other investigators supported 
to pursue research projects in the National Institute on 
Drug Abuse (NIDA) STTR portfolio [26, 27]. Most sec-
tions of the assessment were interviewer-administered, 
while sections containing potentially sensitive questions 
(e.g., questions regarding sexual partners, HIV disclosure, 
Table 2 LINC 1ST intervention session components
Brainstorming client strengths
Developing goals related to obtaining HIV and addiction care
Showing an informational video about HIV and ART
Providing a map of location of HIV clinics
Providing phone numbers to the HIV clinic
Discussing barriers to receiving HIV care and how to overcome them
Discussing what case management was and how the case manager could assist the client
Discussing options for addiction care
Discussing the client’s most recent CD4 cell count and what it means in terms of HIV care and receiving ART
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HIV stigma, depressive symptoms, partner violence and 
sexual assault) were self-administered. All assessment 
data were entered directly into study computers. Dur-
ing a reminder call that took place 3 months post-enroll-
ment, participants were asked about the number of times 
they had overdosed since the baseline interview.
In addition to study questionnaires, at each study visit 
RAs measured and recorded participants’ blood pressure, 
height, and weight. Blood was collected for CD4 count 
testing at baseline and 12-months.
Outcomes
The study aimed to test the hypotheses that participants 
randomized to the LINC intervention would have better: 
(1) initiation of HIV care; (2) retention in HIV care; (3) 
receipt of appropriate HIV care; and (4) HIV health out-
comes, as compared to the control group. The primary 
outcome for hypothesis 1 (initiation of HIV care) was 
defined as at least one HIV physician appointment within 
6  months of enrollment, assessed by medical record 
review (Fig.  3). A secondary outcome was self-reported 
Table 3 Study activities and assessment
a Also performed during pre-screening
Study activity Baseline LINC 6-Month follow up LINC 12-Month follow up LINC
Study Assessment x x x
Blood collection for CD4 cell count x x
Medical chart reviewsa x x
Payments $10 $50 $50
Table 4 Components of LINC baseline assessment
A number of measures used were modified from validated instruments
a Self-administered sections
Baseline assessment components Description
Demographics [31] Participant demographics and socio-economic status
HIV Testing and HCV Diagnosis [32] Dates and locations of HIV/HCV testing and HIV/HCV treatment
Health Care Utilization How often participants see a physician and if they receive treatment for HIV and 
addiction
Access to Care Scale [33, 34] Participant perceptions of access to medical care
Barriers to Medical Care [35] Reasons why participants may not have received medical care in the past month
Health Literacy [36] Participant understanding of medical information and forms
HIV Symptom Index [37] A 20-item HIV symptom index of patient-reported symptoms
Sexually Transmitted Diseases Assesses if participants have ever been treated for sexually transmitted diseases
HIV Sex Risk Behaviors [38] Questions about vaginal, oral, and/or anal sexual practices with any sexual part-
ners and use of substances before or during sex
Sexual Partnersa Questions about number and gender of recent sexual partners
HIV Disclosurea [39, 40] Discussion of HIV status with others, including sexual partners
HIV Stigmaa [41] Experiences and feelings participants may have because of HIV
Center for Epidemiologic Studies-Depression Scale (CES-D)a [42, 43] A measure of depressive symptomatology
State Trait Anxiety Inventory (STAI)– Short Forma [44, 45] A measure of current feelings of anxiety
Partner Violence and Sexual Assaulta Experiences of having been hurt physically or sexually
The Fagerstrom Test for Nicotine Dependence [46, 47] A measure of nicotine dependence
Alcohol Use Disorders Identification Test (AUDIT) [48] Identifies persons with hazardous alcohol use
Texas Christian University (TCU): Drug Screen [49, 50] Assesses drug use in the past year
Drug Use [51, 52] Assesses frequency and type of drugs used and drug risk behaviors
Overdose and Suicide [53] Questions regarding overdose and suicide attempts
Household Food Insecurity Access Scale (HFIAS) [54] Assesses access to food in the past 4 weeks
Barratt Impulsiveness Scale [55] Assesses participant impulsivity
Social Support Scale [56] Measures access to companionship, assistance, or other types of support
Involvement with Police [57] Assesses experiences with police officers
RAND36 Health Survey [58] General assessment of overall health
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initiation of HIV care. The primary outcome for hypoth-
esis 2 (retention in HIV care) was defined as at least one 
HIV physician appointment in each of the two consecu-
tive 6  month periods within 12  months of enrollment, 
assessed by medical record review. A secondary outcome 
was self-reported retention in HIV care. The primary 
outcome for hypothesis 3 was receipt of appropriate HIV 
care, defined as a CD4 cell count assessed and ART pre-
scribed if CD4 is <350, or if >350 then another CD4 cell 
count obtained within 12 months. The primary outcome 
for hypothesis 4 was CD4 count obtained during the 
12-month research visit. A secondary outcome was any 
self-reported hospitalizations.
Data were collected from patient medical charts to 
assess the study’s primary outcomes of participant initia-
tion of and retention in HIV care, as well as the appro-
priateness of HIV care. Chart reviews were conducted at 
two central HIV care centers, where study participants 
were expected to seek HIV medical care: Botkin Infec-
tious Disease Hospital and City AIDS Center. In Russia, 
government-funded care is sought and provided based on 
the patient’s address. Patients who seek addiction care at 
the City Addiction Hospital, the LINC recruitment site, 
would receive HIV care at either the City AIDS Center 
or Botkin Infectious Disease Hospital. Although eligibil-
ity criteria stipulated that participants should be willing 
to receive care from Botkin Infectious Disease Hospital, 
they were not required to do so. After initial care is estab-
lished at one of these main hospitals, patients are able to 
receive follow-up care at local clinics. At Botkin Hospital, 
every 3–4 months a study staff member conducted chart 
reviews on all participants, who were 6 or 12  months 
post-baseline, and entered data directly into a web-based 
chart review form. At the City AIDS Center chart reviews 
were conducted annually for all participants who were 
12 months post-baseline by local hospital staff trained by 
a Russian co-investigator (EB) and the study staff mem-
ber who conducted the chart review at Botkin Hospital. 
Chart review information was entered onto paper forms 
and subsequently transferred to the main research site at 
First St. Petersburg Pavlov State Medical University and 
entered into the online chart review form by a study staff 
member. For a small number (n  <  20) of participants, 
whose City AIDS Center charts indicated the receipt of 
HIV care from a district clinic, or if participants reported 
receiving HIV care elsewhere, medical charts were 
sought for review from those locations. Data obtained 
from patient medical charts included clinic visit dates, 
CD4 testing dates and results, and ART information.
Loss to follow-up was a concern in this difficult-to-
track population, which included not only those diffi-
cult to contact (e.g., actively using substances), but also 
deaths and incarcerations. However, loss to follow-up 
was minimized by using medical record review to obtain 
data for three of the four primary outcomes. The research 
team had previous experience with long-term follow-
up of similar participants, analysis of incomplete longi-
tudinal data, and medical record review of clinical data 
using a standard protocol, which minimized incomplete 
observations.
Analytic methods
Descriptive statistics will be calculated for all variables at 
baseline, 6-, and 12-months. All baseline variables will be 
assessed to ascertain important differences across treat-
ment arms. Spearman correlation analyses will be per-
formed to identify pairs of covariates that are correlated 
(r > 0.4) and would therefore not be included together in 
regression analyses. All analyses will use the intention-
to-treat approach and analyze participants according to 
randomized group.
To assess initiation, retention and appropriateness of 
HIV medical care, initial analyses will be performed com-
paring these binary outcomes between groups using a 
Chi square test. The primary analysis will use multivaria-
ble logistic regression analyses to control for stratification 
factors (i.e., outpatient appointment with an HIV doctor 
in the past 12 months, ever having been hospitalized for 
Table 5 Components of the LINC 6- and 12-month assessment
A number of measures used were modified from validated instruments
a Also includes all Baseline Assessment Components except Health Literacy, Sexually Transmitted Diseases, HIV Disclosure, and Involvement with Police; 12-month 
Assessment Components are the same as 6-month Assessment Components with the exception of Reproductive Health section (6-months only)
b Self-administered section
Follow up assessment componentsa Description
ART Use and Adherence [59–61] Questions on ART use and 30-day adherence
Opportunistic Infections [62] Assesses any history of candida or yeast infection of the esophagus, TB, pneumonia, or toxoplasmosis
Barriers to Medical Care: Drug Use [63] Assesses if drug use has affected access to medical care
Perceived Discrimination in Health Careb [64] Assesses participant’s perceived discrimination in health care because of their drug use
Case Manager Questionsb Assess participant’s feelings and experiences related to case management
Reproductive Health [65] Questions regarding reproductive health for female participants
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HIV infection) in order to improve efficiency. Exploratory 
analyses will be conducted to examine whether or not 
there were effects due to HIV care site. The primary out-
come for HIV health (i.e., CD4 cell count at 12 months) 
is continuous and will be analyzed using multiple linear 
regression models controlling for stratification factors 
and any baseline characteristics that differ.
Power calculations assumed a 2-sided test, with a sig-
nificance level of 0.05. It was expected that 350 patients 
would be enrolled into the study. Because the primary 
outcome for the overall study, initiation of HIV care, 
was assessed using medical records, we expected loss to 
follow-up to be minimal. Based on a prior study from 
this research team (i.e., the HERMITAGE study), we 
estimated a 10 % loss to follow-up due to death and par-
ticipant withdrawals [28]. According to data collected 
at another Russian narcology hospital, the Leningrad 
Regional Center for Addiction, by our Russian collabo-
rators (EK, EB), we expected 20 % of controls to attend 
one or more appointments in 6 months. Based on these 
assumptions and with 315 evaluable participants, the 
study has 80  % power to detect an absolute difference 
of 15 % (i.e., 35 vs. 20 % in the intervention and control 
groups, respectively) in the proportions initiating HIV 
care using a Chi square test with continuity correction.
Protection of study participants and study data
The LINC study was approved by the Institutional Review 
Boards of Boston University Medical Campus and First 
St. Petersburg Pavlov State Medical University. All study 
participants completed the informed consent process 
and provided written informed consent. Serious Adverse 
Events (i.e., hospitalizations and deaths) were reported by 
the study team to the study Principal Investigator (JS), as 
the team became aware of their occurrence. Events were 
reported to the Institutional Review Board annually.
With the exception of medical record review at the City 
AIDS Center, which was collected on paper and entered 
later, all study data were captured electronically on study 
computers via a secure, web-based data capture system. 
Access to the system was protected via secure logins and all 
data transmissions were encrypted using secure socket lay-
ering. Study data were housed on secure servers maintained 
by the Boston University Office of Information Technology, 
Chart found 
Linked to HIV care Did not link to HIV care
Medical chart sought at HIV clinic
Medical chart documentation of 
attendance at HIV clinic within 
the specified time period
Yes No
No chart found 
Did not link to HIV care
Outcomes
Fig. 3 LINC medical record review flow chart
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behind the Boston University firewalls. Identifiers needed to 
track participants were kept separate from research data in a 
secure database to which access was restricted.
Discussion and potential impact
The LINC study tests the effectiveness of a pragmatic 
intervention to engage HIV-infected PWID in HIV medi-
cal care by attempting to link HIV and narcology systems 
within the Russian medical care context. Given that a 
substantial fraction of Russian HIV-infected PWID are 
untreated in terms of their HIV infection, and current 
HIV testing for all patients at high risk for HIV already 
occurs as standard practice in narcology hospitals, an 
effective linkage clinical approach would be of great value 
[29]. Adapting an approach demonstrated to improve 
linkage in the United States is a reasonable start, but 
much is different in the Russian context and hence exten-
sive efforts to adapt and train the “peer” case managers, 
as described in this protocol, are necessary. Since opioid 
agonist treatment (OAT) is not permitted nor accessible 
in Russia, the LINC intervention would be carried out 
primarily among people actively injecting drugs, typically 
opioids. According to Russian guidelines ART is initiated 
at CD4 cell counts below 350 cells/mm3; these guidelines 
are not conditional on one’s drug use behavior. The prag-
matic features of the LINC intervention are important, 
as hospitals could utilize the relatively new, but already 
existing position of HIV case managers (CMs) in some 
parts of Russia. Thus, the LINC protocol could be imple-
mented without significantly changing the structure of 
care delivery in Russia. The peer-led case management 
sessions being tested in this LINC study empower nar-
cology hospital patients to achieve goals that they set for 
themselves and work to keep the patients accountable for 
these goals throughout the case management sessions.
This LINC study will examine whether the intervention 
will improve the initiation and retention of participants 
in HIV care, lead to receipt of appropriate HIV care and 
result in better HIV health outcomes. It is clear that the 
intervention most directly targets the process of initiation 
of care and will depend on a functioning HIV health care 
system to facilitate subsequent health outcomes. This is 
a logical consequence demonstrated in other settings, in 
which a higher percentage of HIV patients who received 
more frequent and continuous HIV care achieved viral 
suppression, compared to those who received HIV care 
less frequently, but its occurrence in the Russian setting 
merits examination as per the study protocol [30]. The 
LINC intervention optimizes resources already available 
in Russia to initiate and retain HIV-infected PWID in 
appropriate HIV care. It will potentially address a criti-
cal aspect of the seek, test, treat and retain (STTR) strat-
egy to contribute to the global effort to improve health 
systems’ performance to advance HIV-infected individu-
als down the HIV care cascade, particularly PWID within 
the addiction treatment setting.
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